Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4′ benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulations

References

• Andujar, S. A., Lugli, F., Höfinger, S., Enriza, R. D., & Zerbetto, F. (2012). Amyloid-β oligomer disruption by C60 – Molecular guidance for rational drug design. Physical Chemistry Chemical Physics, 14, 8599–8607.
   PubMed Web of Science ®Google Scholar
• Autiero, I., Langella, E., & Saviano, M. (2013). Insights into the mechanism of interaction between trehalose-conjugated beta-sheet breaker peptides and Aβ(1-42) oligomers by molecular dynamics simulations. Molecular Biosystems, 9, 2835–2841.
   PubMed Web of Science ®Google Scholar
• Baptista, F. I., Henriques, A. G., Silva, A. M., Wiltfang, J., & da Cruz e Silva, O. A. (2014). Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. ACS Chemical Neuroscience, 5, 83–92.
   PubMed Web of Science ®Google Scholar
• Bastianetto, S., Krantic, S., & Quirion, R. (2008). Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer's disease. Mini Reviews Medicinal Chemistry, 8, 429–435.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Van der Spoel, D., & Drunen, R. V. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91, 43–56.
   Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2010). Natural polyphenols as inhibitors of amyloid aggregation: Molecular dynamics study of GNNQQNY heptapeptide decamer. Biophysical Chemistry, 149, 12–21.
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2011). Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN. Journal of Molecular Modeling, 17, 2423–2442.
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2014a). Full length amylin oligomer aggregation: insights from molecular dynamics simulations and implications for design of aggregation inhibitors. Journal of Biomolecular Structure Dynamics, 32, 1651–1669.
   PubMed Web of Science ®Google Scholar
• Berhanu, W. M., & Masunov, A. E. (2014b). The atomic level interaction of polyphenols with the Aβ oligomer aggregate, a molecular dynamic guidance for rational drug design. In R. R. Watson, V. R. Preedy, & S. Zibadi (Eds.), Polyphenols in Human Health and Disease (pp. 59–70). San Diego, CA: Academic Press, Elsevier.
   Google Scholar
• Biancalana, M., Makabe, K., Koide, A., & Koide, S. (2009). Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies. Journal of Molecular Biology, 385, 1052–1063.
   PubMed Web of Science ®Google Scholar
• Choi, Y., Kim, T. D., Paik, S. R., Jeong, K., & Jung, S. (2008). Molecular simulations for anti-amyloidogenic effect of flavonoid myricetin exerted against Alzheimer’s β-amyloid oligomers formation. Bulletin of the Korean Chemical Society, 29, 1505–1509.
   Web of Science ®Google Scholar
• Claus, P., & Behl, C. (2005). Concepts for the treatment of Alzheimer’s disease: Molecular mechanisms and clinical application. Int J Exp Pathol, 86, 173–185.
   PubMed Web of Science ®Google Scholar
• Davis, C. H., & Berkowitz, M. L. (2009). Interaction between amyloid-β (1–42) peptide and phospholipid bilayers: A molecular dynamics study. Biophysical Journal, 96, 785–797.
   PubMed Web of Science ®Google Scholar
• Esler, W. P., Stimson, E. R., Ghilardi, J. R., Lu, Y. A., Felix, A. M., Vinters, H. V., … Maggio, J. E. (1996). Point substation in the central hydrophobic cluster of a human beta amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry, 35, 13914–13921.
   PubMed Web of Science ®Google Scholar
• Ghatty, V. P. K., & Mostofian, B. (2013). Dynamics of water in the amphiphilic pore of amyloid β oligomers. Chemical Physics Letters, 582(2), 1–5.
   Google Scholar
• Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4, 17–32.
   PubMed Web of Science ®Google Scholar
• Hardy, J. A., & Higgins, G. A. (1992). Alzheimer's disease: The amyloid cascade hypothesis. Science, 256, 184–185.
   PubMed Web of Science ®Google Scholar
• Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297, 353–356.
   PubMed Web of Science ®Google Scholar
• Harper, J. D., & Lansbury, P. T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annual Review of Biochemistry, 66, 385–407.
   PubMed Web of Science ®Google Scholar
• Hikari, I. W., Kamihira-I, M., Javkhlantugs, N., Inoue, R., Yuki, I, Endo, H., … Naito, A. (2013). Role of aromatic residues in amyloid oligomer formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. Physical Chemistry Chemical Physics, 15, 8890–8901.
   PubMed Web of Science ®Google Scholar
• Hilbich, C., Kisters-Woike, B., Masters, C. L., & Beyruether, K. (1992). Substitution of hydrophobic amino acid reduces the amylodogenicity of Alzheimer’s disease beta A4 peptides. Journal of Molecular Biology, 219, 460–473.
   Web of Science ®Google Scholar
• Huy, P. D., Yu, Y. C., Ngo, S. T., Thao, T. V., Chen, C. P., Li, M. S., & Chen, Y. C. (2013). Insilico and Invitro characterization of anti-amyloidogenic activity of vitamin K3 analogues for Alzheimer's disease. Biochim et Biophysica Acta, 1830, 2960–2969.
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., & Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889–897.
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA Calculations. Journal of Chemical Information and Modeling, 54, 1951–1962.
   PubMed Web of Science ®Google Scholar
• Lemkul, A. J., & Bevan, D. R. (2010). Destabilizing Alzheimer’s Aβ42 protooligomers with morin: Mechanistic insights from molecular dynamics simulations. Biochemistry, 49, 3935–3946.
   PubMed Web of Science ®Google Scholar
• LeVine, H., 3rd. (2005). Multiple ligand binding sites on A beta(1–40) oligomers. Amyloid, 12, 5–14.
   PubMed Web of Science ®Google Scholar
• Lindahl, E., Hess, B., & Van der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modelling, 7, 306–317.
   Web of Science ®Google Scholar
• Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., … Brown, J. (2005). Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on beta-amyloid peptide oligomers. Journal of Biological Chemistry, 280, 7677–7684.
   PubMed Web of Science ®Google Scholar
• Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., … Riek, R. (2005). 3D structure of Alzheimer's amyloid-beta(1–42) oligomers. Proceedings of the National Academy of Sciences of the United States of America, 102, 17342–17347.
   PubMed Web of Science ®Google Scholar
• Medina-Franco, J. L., López-Vallejo, F., Kuck, D., & Lyko, F. (2011). Natural products as DNA methyltransferase inhibitors: A computer-aided discovery approach. Molecular Diversity, 15(2), 1–12.
   Web of Science ®Google Scholar
• Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2009). Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein oligomerlation. Biochemistry, 48, 8206–8224.
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity. Journal of Computational Chemistry, 16, 2785–2791.
   Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C. A., Morley, C., Vandermeersch, T., & Hutchison, G.R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33.
   PubMed Web of Science ®Google Scholar
• Porat, Y., Abramowitz, A., & Gazit, E. (2006). Inhibition of amyloid oligomer formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chemical Biology and Drug Design, 67, 27–37.
   PubMed Web of Science ®Google Scholar
• Reddy, G., Straub, J. E., & Thirumalai, D. (2009). Influence of preformed Asp23-Lys28 salt bridge on the conformational fluctuations of monomers and dimers of Abeta peptides with implications for rates of oligomer formation. Journal of Physical Chemistry B, 113, 1162–1172.
   PubMed Web of Science ®Google Scholar
• Richard, T., Papastamoulis, Y., Waffo-Teguo, P., & Monti, J. P. (2013). 3D NMR structure of a complex between the amyloid beta peptide (1–40) and the polyphenol ε-viniferin glucoside: Implications in Alzheimer's disease. Biochimica et Biophysica Acta, 1830, 5068–5074.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Rodríguez, C., Rimola, A., Rodríguez-Santiago, L., Ugliengo, P., Alvarez-Larena, A., Gutiérrez-de-Terán, H., … González-Duarte, P. (2010). Crystal structure of thioflavin-T and its binding to amyloid oligomers insights at the molecular level. Chemical Communications, 46, 1156–1158.
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & VanAalten, D. M. F. (2004). PRODRG-a tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica D, 60, 1355–1363.
   PubMed Web of Science ®Google Scholar
• Singh, S. K., Gaur, R., Kumar, A., Fatima, R., Mishra, L., & Srikrishna, S. (2014). The flavonoid derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: Insights from in silico and in vivo studies. Neurotoxicity Research, 26, 331–350.
   PubMed Web of Science ®Google Scholar
• Takeda, T., Chang, W. E., Raman, E. P., & Klimov, D. K. (2010). Binding of non-steroidal anti-inflammatory drugs to Aβ oligomer. Proteins, 78, 2849–2860.
   PubMed Web of Science ®Google Scholar
• Thies, W., & Bleiler, L. (2013). Report Alzheimer disease facts and figures. Alzheimer’s Dement, 9, 208–245.
   PubMed Web of Science ®Google Scholar
• Verma, S., Singh, A., & Mishra, A. (2013). The effect of fulvic acid on pre- and postaggregation state of Aβ(17-42): Molecular dynamics simulation studies. Biochimica et Biophysica Acta, 1834, 24–33.
   PubMed Web of Science ®Google Scholar
• Wu, C., Wang, Z., Lei, H., Zhang, W., & Duan, Y. (2007). Dual binding modes of Congo red to amyloid protooligomer surface observed in molecular dynamics simulations. Journal of the American Chemical Society, 129, 1225–1232.
   PubMed Web of Science ®Google Scholar
• Wu, C., Wang, Z., Lei, H., Duan, Y., Bowers, M. T., & Shea, J. E. (2008). The binding of thioflavin T and its neutral analog BTA-1 to protooligomers of the Alzheimer's disease Abeta(16–22) peptide probed by molecular dynamics simulations. Journal of Molecular Biology, 384, 718–729.
   PubMed Web of Science ®Google Scholar
• Yang, C., Zhu, X., Li, J., & Shi, R. (2010). Exploration of the mechanism for LPFFD inhibiting the formation of β-sheet conformation of Aβ(1–42) in water. Journal of Molecular Modeling, 16, 813–821.
   PubMed Web of Science ®Google Scholar